US drug deals take months, EU laws take years: “It might be too late”

EU PERSPECTIVES - Fewer new medicines are reaching European patients, and the factories that could make them are going up in America. Alexander Natz, who speaks for Europe's smaller drugmakers, warns that new EU laws may come too late to reverse it. He wants Brussels to use the rules it already has. Read more

Alexander Natz wants Europe to use the tools it already has / Photo: EHFG